Top gainers, losers, and the catalysts behind the move
Start with the names driving price and volume, then decide which ones deserve a deeper look across screens, comparison, or valuation.
| # | Symbol | Price | Change | Volume | Mkt Cap | Driver | AI Insight |
|---|---|---|---|---|---|---|---|
| 1 | $5.42 | +24.20% | 394K | $287.0M | — | — | |
| 2 | $23.75 | +23.70% | 1.5M | $937.4M | — | — | |
| 3 | $75.40 | +17.43% | 15.2M | $3.9B | — | — | |
| 4 | $2.05 | +15.72% | 9.4M | $260.6M | — | — | |
| 5 | $50.72 | +14.13% | 31K | $132.1M | — | — | |
| 6 | $9.32 | +12.02% | 98K | $740.4M | — | — | |
| 7 | $3.38 | +11.92% | 1.9M | $132.9M | — | — | |
| 8 | $13.02 | +11.86% | 80K | $387.8M | — | — | |
| 9 | $12.51 | +11.20% | 75K | $105.4M | — | — | |
| 10 | $22.52 | +10.39% | 115K | $382.8M | — | — |
Fresh analysis from the VCP Scanner news pipeline
Freshly published articles covering earnings, market movers, and company-specific setups tied to the same tickers you can research across the site.
AMD: Zuckerberg's AI Agent Vision, Baird's $1,250 Target, and the Margin Question
AMD is at the center of the AI infrastructure buildout, but flat gross margins and a post-earnings selloff raise questions about how much upside is left.
JNJ Hits 52-Week High Territory: Can a $629B Healthcare Giant Justify Its 30x Trailing P/E?
With blockbuster drug sales and a pending spinoff, J&J is firing on all cylinders — but valuation and insider selling give us pause.
Home Depot's Q2 Report Looms: Can a 24x Premium Survive a Slowing Housing Market?
With shares up just 3% YTD and a premium valuation, HD's Aug. 18 earnings will test whether the market's optimism is justified.
P&G: The 70-Year Dividend King Just Got Cheaper — Time to Buy the Dip?
With shares down near 52-week lows and a 3% yield backed by 70 straight years of dividend hikes, Procter & Gamble is the defensive play for a market that's starting to wobble.